Trial Profile

A First in Human Feasibility Study of T Regulatory Cells (TR004) for Inflammatory Bowel Disease Using (ex Vivo) Treg Expansion

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 29 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TR 004 (Primary)
Indications Crohn's disease
Focus Adverse reactions; First in man
Acronyms TRIBUTE

Most Recent Events

27 Jan 2023 According to ClinicalTrials.gov record, protocol has been amended to decrease the patient number from 24 to 4, study arm will be 1, study will not be randomised.
27 Jan 2023 Planned number of patients changed from 24 to 4.
27 Jan 2023 Planned End Date changed from 1 Sep 2021 to 30 Jun 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com